Dacarbazine is an alkylating agent used in chemotherapy for treating melanoma and Hodgkin’s lymphoma. It works by methylating DNA, leading to the inhibition of DNA synthesis and function. It is grouped under the following drug class(es): Alkylating agents, Antineoplastic agents and Cytotoxics. Its therapeutic use is listed as anti-cancer agents and antineoplastics. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Detimedac, Asercit and Fauldetic. Its PubChem CID is 135398738.
Dacarbazine
| CAS No | 4342-03-4 |
|---|---|
| Molecular Formula | C6H10N6O |
| Molecular Weight | 182.18 g/mol |
| Synonyms | 4-[(E)-dimethylaminodiazenyl]-1H-imidazole-5-carboxamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Dacarbazine is an alkylating agent used in chemotherapy for treating melanoma and Hodgkin's lymphoma. It works by methylating DNA, leading to the inhibition of DNA synthesis and function.
The listed CAS number is 4342-03-4.
The listed molecular formula is C6H10N6O.
The listed molecular weight is 182.18 g/mol.
4-[(E)-dimethylaminodiazenyl]-1H-imidazole-5-carboxamide.
The source lists Detimedac, Asercit and Fauldetic.